之江生物
(688317)
| 流通市值：44.64亿 | | | 总市值：44.64亿 |
| 流通股本：1.92亿 | | | 总股本：1.92亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,505,157,120.55 | 2,642,785,204.33 | 2,783,392,638.52 | 2,744,475,186.36 |
| 交易性金融资产 | 312,803,621.6 | 148,713,464.12 | - | - |
| 应收票据及应收账款 | 40,737,980.24 | 50,137,606.51 | 55,266,044.02 | 76,228,303.43 |
| 其中：应收票据 | 846,332.96 | 2,218,598.82 | 247,022 | 879,546 |
| 应收账款 | 39,891,647.28 | 47,919,007.69 | 55,019,022.02 | 75,348,757.43 |
| 预付款项 | 10,496,453.65 | 10,357,982.22 | 11,838,697.34 | 12,788,745.39 |
| 其他应收款合计 | 4,837,407.18 | 5,082,368.97 | 4,635,986.13 | 6,901,504.14 |
| 存货 | 53,542,663.96 | 50,647,478.79 | 57,369,192.76 | 213,761,093.04 |
| 其他流动资产 | 23,724,435.02 | 23,656,750.16 | 23,103,214.83 | 18,123,637.24 |
| 流动资产合计 | 2,951,299,682.2 | 2,931,380,855.1 | 2,935,605,773.6 | 3,072,278,469.6 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 95,590,922.01 | 95,405,975.75 | 95,461,701.3 | 97,497,105.22 |
| 投资性房地产 | - | - | 0 | - |
| 固定资产 | 651,367,258.01 | 664,189,253.89 | 675,576,117.73 | 704,264,631.87 |
| 在建工程 | 1,317,669.53 | 1,226,580.42 | 343,000 | 42,600 |
| 使用权资产 | 4,207,562.86 | 4,536,252.46 | 5,028,587.15 | 5,013,958.25 |
| 无形资产 | 7,246,529.91 | 7,258,725.83 | 7,800,921.75 | 5,394,713.01 |
| 商誉 | 5,404,994.34 | 5,404,994.34 | 5,404,994.34 | 5,404,994.34 |
| 长期待摊费用 | 3,470,647.84 | 3,648,943.97 | 3,824,633.06 | 3,968,822.15 |
| 递延所得税资产 | 58,583,948.09 | 60,208,576.17 | 60,797,766.19 | 40,183,918.06 |
| 其他非流动资产 | - | 265,000 | 106,596 | 2,431,051.32 |
| 非流动资产合计 | 827,189,532.59 | 842,144,302.83 | 854,344,317.52 | 864,201,794.22 |
| 资产总计 | 3,778,489,214.79 | 3,773,525,157.93 | 3,789,950,091.12 | 3,936,480,263.82 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 68,101,121.39 | 74,140,312.17 | 78,752,406.72 | 78,107,635.31 |
| 应付账款 | 68,101,121.39 | 74,140,312.17 | 78,752,406.72 | 78,107,635.31 |
| 合同负债 | 15,055,605.64 | 12,166,719.22 | 15,280,381.97 | 13,419,119.45 |
| 应付职工薪酬 | 35,561,631.78 | 37,947,350.89 | 40,929,438.43 | 51,975,759.14 |
| 应交税费 | 2,759,328.24 | 3,087,033.49 | 3,023,577.08 | 3,202,379.82 |
| 其他应付款合计 | 6,021,864.48 | 6,321,547.67 | 5,791,518.97 | 5,846,561.96 |
| 一年内到期的非流动负债 | 1,256,940.03 | 1,680,955.69 | 1,732,454.28 | 1,464,821.36 |
| 其他流动负债 | 1,452,145.13 | 1,572,026.81 | 478,810.09 | 462,527.75 |
| 流动负债合计 | 130,208,636.69 | 136,915,945.94 | 145,988,587.54 | 154,478,804.79 |
| 非流动负债: | | | | |
| 长期借款 | 198,000,000 | 99,000,000 | - | - |
| 租赁负债 | 2,792,906.19 | 3,090,321.31 | 3,193,894.52 | 3,880,552.35 |
| 递延收益 | 1,838,070.24 | 2,712,350.44 | 3,880,846.55 | 4,716,698.41 |
| 非流动负债合计 | 202,630,976.43 | 104,802,671.75 | 7,074,741.07 | 8,597,250.76 |
| 负债合计 | 332,839,613.12 | 241,718,617.69 | 153,063,328.61 | 163,076,055.55 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 192,157,999 | 192,157,999 | 192,157,999 | 192,157,999 |
| 资本公积 | 2,050,702,003.19 | 2,050,702,003.19 | 2,050,702,003.19 | 2,050,702,003.19 |
| 减:库存股 | 217,259,424.86 | 124,380,266.25 | 35,331,332.71 | 35,331,332.71 |
| 其他综合收益 | -8,340,834.38 | -8,896,694.19 | -8,882,738.46 | -7,700,635.79 |
| 盈余公积 | 97,352,175 | 97,352,175 | 97,352,175 | 97,352,175 |
| 未分配利润 | 1,331,037,683.72 | 1,324,871,323.49 | 1,340,888,656.49 | 1,476,223,999.58 |
| 归属于母公司股东权益合计 | 3,445,649,601.67 | 3,531,806,540.24 | 3,636,886,762.51 | 3,773,404,208.27 |
| 股东权益合计 | 3,445,649,601.67 | 3,531,806,540.24 | 3,636,886,762.51 | 3,773,404,208.27 |
| 负债和股东权益合计 | 3,778,489,214.79 | 3,773,525,157.93 | 3,789,950,091.12 | 3,936,480,263.82 |
| 公告日期 | 2025-08-29 | 2025-04-30 | 2025-04-25 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |